BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 15056096)

  • 1. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
    Björnsson E; Angulo P
    Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M; Elinav H; Goldin E; Ilan Y
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis.
    Tanaka A; Takamori Y; Toda G; Ohnishi S; Takikawa H
    Liver Int; 2008 Aug; 28(7):983-9. PubMed ID: 18397233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.
    Kaya M; de Groen PC; Angulo P; Nagorney DM; Gunderson LL; Gores GJ; Haddock MG; Lindor KD
    Am J Gastroenterol; 2001 Apr; 96(4):1164-9. PubMed ID: 11316165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
    Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
    Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
    Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.